Online inquiry

IVTScrip™ mRNA-Human ARNTL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28664MR)

This product GTTS-WK28664MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARNTL2 protein. This product can be used in FOXN4+ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001248002.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 56938
UniProt ID Q8WYA1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARNTL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28664MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK27124MR IVTScrip™ mRNA-Human ARID3B, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARID3B
GTTS-WK26819MR IVTScrip™ mRNA-Human ARHGEF39, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF39
GTTS-WK27482MR IVTScrip™ mRNA-Human ARRDC4, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARRDC4
GTTS-WK6399MR IVTScrip™ mRNA-Human CD59, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA CD59
GTTS-WK14100MR IVTScrip™ mRNA-Human Aggrecan, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA Aggrecan
GTTS-WK16144MR IVTScrip™ mRNA-Human Annexin V, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Annexin V
GTTS-WK28659MR IVTScrip™ mRNA-Human ARMCX2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARMCX2
GTTS-WK27093MR IVTScrip™ mRNA-Human ARHGAP29, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP29
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW